Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
chronic lymphocytic leukemia up-regulated 1 | 1.000 | 0.115 | 1.7E-03 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2006 | 2019 | ||||||||
|
immunoglobulin lambda variable 3-21 | 1.000 | 0.115 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2005 | 2019 | |||||||||
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) | 0.931 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2014 | |||||||||
|
immunoglobulin heavy diversity 3-3 | 1.000 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2001 | |||||||||
|
immunoglobulin kappa variable 2-30 | 1.000 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2016 | |||||||||
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) | 1.000 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2014 | |||||||||
|
DACT3 antisense RNA 1 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
Mental retardation, autosomal dominant 4 | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
ring finger protein 217 | 0.839 | 0.115 | 2.0E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
fragile site, folic acid type, rare, fra(16)(p13.11) | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
myelodysplastic syndrome 2 translocation associated | 0.861 | 0.115 | 0.38 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
immunoglobulin heavy variable 4-38-2 | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
immunoglobulin heavy variable 3-41 (pseudogene) | 0.890 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
immunoglobulin heavy variable 3-30 | 0.931 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
immunoglobulin lambda joining 2 | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
immunoglobulin kappa joining 2 | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
immunoglobulin kappa joining 1 | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
C-type lectin domain containing 17A | 1.000 | 0.115 | 9.1E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
microRNA 181b-1 | 0.890 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
lymphocyte transmembrane adaptor 1 | 1.000 | 0.115 | 3.0E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
SPRY domain containing 7 | 0.931 | 0.115 | 2.1E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
dual specificity phosphatase 5 pseudogene 1 | 0.890 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
transmembrane and coiled-coil domain family 3 | 1.000 | 0.115 | 2.7E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
immunoglobulin heavy variable 4-39 | 0.839 | 0.154 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2019 | |||||||||
|
ST13, Hsp70 interacting protein pseudogene 4 | 0.839 | 0.154 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2003 |